G207 with radiation for children with high-grade glioma
Official title: Phase 2 Trial of G207 + 5 Gy Radiation for Children With High-Grade Gliomas
Status: Not yet recruiting. It has not opened yet. Ask your care team to watch for it if it looks like a fit.
The trial team last updated this record on .
The short version
This study is testing a treatment called G207, given with radiation, in children whose high-grade glioma: A tumor that starts in the glial cells, the support cells of the brain and spinal cord. Gliomas are graded 1 to 4 by how fast they tend to grow. See the glossary has come back or is growing.
Read our full plain-language summary
What the trial team says
The goal of this clinical research study is to learn about the safety and effects of G207 combined with radiation therapy in patients with recurrent or progressive high-grade glioma (HGG).
Key facts
- Registry number
- NCT07649070
- Stage of testing
- Phase 2
- Conditions studied
- High Grade Gliomas
Where it is running
This trial lists 1 site.
-
Texas
- UT MD Anderson (Houston)
How to use this
Talk to your care team first. They know your history and can tell you whether this trial is worth your time.
Joining a trial is always your choice. A trial is a test, not a proven treatment. Being in one is not a promise that it will help you.
This page is built from the trial's listing on ClinicalTrials.gov, a service of the U.S. National Library of Medicine. That listing is the authority, and it may have changed since we last read it. We do not run this trial and we cannot enroll you in it.